Good MorningThe tug of war between bulls and bears continued on Thursday with the bears winning out. The rising tide of fear that is driven by inflation and the FOMC’s rapidly accelerating timeline for interest rate hikes has the market on edge. While rising interest rates are a sign of economic expansion and it is very, very early in the rate hiking cycle, there are those who think the FOMC is behind the curve and will raise rates and a much faster pace than seen before.
The latest look at the CME FedWatch Tool shows the market is pricing in at least a 50% chance for 4 interest rate hikes by the end of the year. Based on this week’s CPI and PPI data, we think the first hike will be at least 50 basis points or worth half of the 4 hike outlook. As for the S&P 500, it looks like the market could head lower but earnings season begins today and that could change the entire mood on Wall Street.
Featured: Wall Street’s quietly buying these 3 AI infrastructure plays (Ad) 
|
Markets | |
Space tourism pioneer Virgin Galactic Holdings, Inc. (NYSE: SPCE) stock has collapsed below pandemic lows after its initial space flight carrying its chairman Richard Branson. What initially seemed like a step forward moving towards significant revenue generation was pushed back as the Company del... Read the Full Story |
|
From Our Partners | | BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid.
The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned. | | Get the name, the ticker, and exactly how to buy it |
|
Transportation | |
Industrial Stocks are Appealing in an Uncertain Market
Many of the top analysts on Wall Street are bullish on value sectors like the industrials, and it’s fairly easy to understand why. With interest rate hikes on the horizon and sharp moves to the downside in high valuation names, industri... Read the Full Story |
|
Technology | |
As 2022 goes into full swing, it stands to reason that as the pandemic doesn't impose quite the burden that it once did, consumer discretionary spending will tick upward. After all, nonessential products and services will come into vogue again, right? (Aren't we beyond the need for just toilet pap... Read the Full Story |
|
From Our Partners | | See the Signals Most Traders Miss
We monitor subtle shifts in order flow, volume patterns, and early trend behavior.
Stock News Trends highlights moves long before they hit mainstream screens. | | Join Free — Start Tracking Early Market Data |
|
Technology | |
Infosys Beats And Raises As Transformation Takes Hold
Infosys (NYSE: INFY) has been working hard on a digital transformation that just so happened to set the company up perfectly for the pandemic and the post-pandemic world. A consulting and outsourcing firm, Infosys’ transformation is cen... Read the Full Story |
|
Industrials | |
Analysts And Institutions Put A Bottom In Caterpillar
The analysts have been getting incrementally more bullish on Caterpillar (NYSE: CAT) over the past 12 months and we see this activity driving share prices back to the all-time high set in 2021, at least. Activity since the start of 2022 inclu... Read the Full Story |
|
From Our Partners | | With OpenAI and Anthropic moving closer to the IPO spotlight, AI excitement could spill into several public-market sectors this summer - and most investors may chase the obvious names too late.
A free report identifies 7 stocks positioned around themes that could matter most this summer: AI infrastructure, energy demand, travel, entertainment, home improvement, and more. Built for a market where leadership may rotate quickly. | | Download 7 Best Stocks to Own in Summer 2026 for free |
|
Consumer Discretionary | | Shares of video game maker Take-Two (NASDAQ: TTWO) have had their busiest few days in nearly three years this week as the bulls and the bears slugged it out to see where shares will go next. They’ve had a rough enough start to the year, falling as much as 25% at one point into the start of thi... Read the Full Story |
|
Technology | | Shares of mid-cap Shutterstock (NYSE: SSTK) are down 10.13% this month, following a rally to the tune of 44.55% in the past 12 months.
The company went public in 2012, so it’s well within the “early opportunity” phase where it’s likely to notch some of its biggest gains. Th... Read the Full Story |
|
Construction | |
KB Home Raises The Roof In Q4
Shares of KB Home (NYSE: KBH) pulled back from their 13-year high during 2021 but the institutions put a bottom in the action. The institutional activity was robust during the year and netted $253.35 million in sales over the course of 404 transactions. The activity ... Read the Full Story |
|
Consumer Staples | |
Energy drink maker Monster Beverage (NASDAQ: MNST) shares have been rallying despite the market sell-off on merger speculation. The rising costs of aluminum, shipping costs and supply chain disruptions hurt margins resulting in a miss on in its Q3 2021 earnings report. While the Company doesn&rsqu... Read the Full Story |
|
Technology | |
Consider Adding These 3 Stocks Trading Under $100
One of the most attractive qualities of the stock market is that you don’t necessarily have to be a big spender in order to capitalize on the potential for long-term gains. Quality companies are priced at all different levels, and investors ... Read the Full Story |
|
Friday's Early Bird Stock Of The Day IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina. | | View Today's Stock Pick |
|
